微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 75.81% | 1.41% | 2.11% | 18/159 | 49.59% | 首药控股 | 96.95% | 行业排名> |
| 2026-06-30 | 74.25% | 1.48% | 2.32% | 28/159 | 48.66% | 海创药业 | 97.34% | 行业排名> |
| 2026-03-31 | 72.56% | -8% | -1.99% | 31/159 | 50.28% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 74.03% | -2% | -0.97% | 28/159 | 50.37% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 74.76% | -5.89% | 2.17% | 28/159 | -2.13% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 73.17% | -6.86% | -7.23% | 29/159 | 15.05% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 78.87% | -0.12% | 4.41% | 20/159 | 31.79% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 75.54% | -4.38% | -4.91% | 24/159 | 51.61% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 79.44% | -4.16% | 1.13% | 20/159 | 22.43% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 78.55% | -7.59% | -0.52% | 20/159 | 32.96% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 78.97% | -12.1% | -0.04% | 20/159 | 51.47% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 79% | 8.18% | -4.69% | 26/159 | 51.31% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 82.89% | 24.53% | -2.48% | 15/159 | 32.31% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 85% | 0.01% | -5.39% | 11/159 | 38.22% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 89.84% | 5.71% | 23.03% | 8/159 | 52.66% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 73.02% | -14.08% | 9.71% | 35/159 | 53.51% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 66.56% | 2% | -21.68% | 46/159 | 5.67% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 84.99% | 2% | 0% | 14/159 | 20.91% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 84.99% | 2% | 0% | 14/159 | 54.06% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 84.99% | 2% | 2% | 20/159 | 54.9% | 首药控股 | 99.93% | 行业排名> |